Midday Commentary: AMAG Pharmaceuticals trades up slightly; Brookdale responds to acquisition news

By Rebecca Melvin

New York, Feb. 21 - AMAG Pharmaceuticals Inc.'s 2.5% convertibles, which priced earlier this month, showed up on the Trace tape early Friday, changing hands at 107.125, which was up 0.235 point with shares of the Waltham, Mass.-based specialty pharmaceutical company trading a little lower.

The $200 million AMAG deal priced Feb. 11. With the stock at about $21.47, the bonds traded at 107.125.

U.S. convertibles were quiet again, a New York-based trader said early Friday, with various names in trade but on thin volume.

Brookdale Senior Living Inc.'s convertible bonds and shares traded up after the Brentwood, Tenn.-based operator of assisted-living homes announced it is buying Emeritus Senior Living for about $1.4 billion and assuming $1.4 billion of debt.

The Brookdale 2.75% convertibles due 2018, which priced in the middle of 2011, traded at 128.313 with shares higher.

The Brookdale shares were last at $31.22, which was up $1.13, or 3.8%. But they had hit a 52-week high of $32.85 earlier Friday.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.